StockNews.com initiated coverage on shares of Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) in a report released on Thursday. The firm set a “sell” rating on the basic materials company’s stock.
Arcadia Biosciences Price Performance
Shares of NASDAQ:RKDA opened at $2.21 on Thursday. The business’s 50 day moving average price is $2.57 and its 200-day moving average price is $2.93. The firm has a market capitalization of $2.45 million, a PE ratio of -0.12 and a beta of 0.62. Arcadia Biosciences has a 1 year low of $2.12 and a 1 year high of $8.18.
Institutional Trading of Arcadia Biosciences
A number of institutional investors have recently made changes to their positions in the company. Vanguard Group Inc. acquired a new stake in shares of Arcadia Biosciences in the fourth quarter worth approximately $44,000. Virtu Financial LLC acquired a new stake in shares of Arcadia Biosciences in the fourth quarter worth approximately $34,000. Sabby Management LLC acquired a new stake in shares of Arcadia Biosciences in the first quarter worth approximately $395,000. Millennium Management LLC boosted its stake in shares of Arcadia Biosciences by 444.3% in the fourth quarter. Millennium Management LLC now owns 185,438 shares of the basic materials company’s stock worth $50,000 after acquiring an additional 151,371 shares during the last quarter. Finally, Susquehanna International Group LLP boosted its stake in shares of Arcadia Biosciences by 85.1% in the fourth quarter. Susquehanna International Group LLP now owns 282,419 shares of the basic materials company’s stock worth $77,000 after acquiring an additional 129,811 shares during the last quarter. 17.73% of the stock is owned by institutional investors and hedge funds.
Arcadia Biosciences Company Profile
Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.
See Also
- Five stocks we like better than Arcadia Biosciences
- What is the Australian Securities Exchange (ASX)
- 3 Value Stocks Too Small For Buffett’s Portfolio
- Market Cap Calculator: How to Calculate Market Cap
- Foot Locker Builds Up Another Head of Steam; Gains Imminent
- What is the Dogs of the Dow Strategy? Overview and Examples
- Disney Stock Catches 3 Upgrades In a Single Week
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
